Skip to main content

Advertisement

Fig. 3 | BMC Microbiology

Fig. 3

From: SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry

Fig. 3

Anti-HIV-1 activity of SJP-L-5. a Lab-adapted strains HIV-1IIIB, HIV-1MN, and HIV-1RF infect C8166 cells, and they were used to measure the antiviral activity of SJP-L-5. The EC50s of these strains ranged from 0.16–0.97 μg/ml. b Clinical isolates HIV-1KM018, HIV-1TC-2, and HIV-1WAN are used to infect PBMC cells and were measured the antiviral activity of SJP-L-5. The EC50s of these primary isolates ranged from 1.96–5.33 μg/ml

Back to article page